Abstract
Mohs micrographic surgery (MMS) for basal cell carcinoma (BCC) is indicated for patients at high risk of recurrence; other therapies, including standard surgical excision, cryotherapy, electrodesiccation and curettage, and radiotherapy, are used in low-risk BCC and in patients who cannot undergo surgery. However, in the case of recurrence following treatment with any of these methods, MMS is indicated. This study aimed to examine how preoperative treatment before MMS affects the recurrence rate after surgery. We conducted a meta-analysis to compare the recurrence rates of primary BCC and previously treated BCC in patients undergoing MMS, with a 5-year follow-up. The secondary outcomes were the recurrence rate after MMS based on previous radiation therapy status, mean time to recurrence, and number of cases undergoing more than one stage of MMS. The recurrence rate in the previously treated group was 2.44 times greater than that of the primary BCC group. In the previous treatment group, the patients who underwent previous radiation showed a 2.52-fold higher recurrence rate than those with no previous radiation therapy. However, there was no significant difference in the mean time to recurrence and the number of cases requiring MMS > 1 stage between the previously treated and non-treated groups. Patients with previously treated BCC, especially those treated using radiation, had a higher likelihood of recurrence.
Similar content being viewed by others
Data /Code availability
All data generated or analyzed during this study are included in this published article and its supplementary information files.
Data Availability
The datasets supporting the conclusions of this article are available in the supplementary file 1.
References
Kim DP, Kus KJB, Ruiz E (2019) Basal cell carcinoma review. Hematol Oncol Clin N Am 33:13–24. https://doi.org/10.1016/j.hoc.2018.09.004
Kang S, Amagai M, Bruckner A, Enk A, Margolis D, McMichael A, Orringer J (2019) Fitzpatrick’s dermatology, 9th edn. McGraw-Hill, New York
Smeets NW, Krekels GA, Ostertag JU, Essers BA, Dirksen CD, Nieman FH, Neumann HA (2004) Surgical excision vs Mohs’ micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364:1766–1772. https://doi.org/10.1016/S0140-6736(04)17399-6
Cameron MC, Lee E, Hibler BP, Giordano CN, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM (2019) Basal cell carcinoma: contemporary approaches to diagnosis, treatment, and prevention. J Am Acad Dermatol 80:321–339. https://doi.org/10.1016/j.jaad.2018.02.083
Bichakjian CK, Olencki T, Aasi SZ, Alam M, Andersen JS, Berg D, Bowen GM, Cheney RT, Daniels GA, Glass LF, Grekin RC, Grossman K, Higgins SA, Ho AL, Lewis KD, Lydiatt DD, Nehal KS, Nghiem P, Olsen EA, Schmults CD, Sekulic A, Shaha AR, Thorstad WL, Tuli M, Urist MM, Wang TS, Wong SL, Zic JA, Hoffmann KG, Engh A (2016) Basal cell skin cancer, version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw Version 1(14):574–597. https://doi.org/10.6004/jnccn.2016.0065
Smeets NWJ, Kuijpers DIM, Nelemans P, Ostertag JU, Verhaegh MEJM, Krekels GAM, Neumann HA (2004) Mohs’ micrographic surgery for treatment of basal cell carcinoma of the face–results of a retrospective study and review of the literature. Br J Dermatol 151:141–147. https://doi.org/10.1111/j.1365-2133.2004.06047.x
Moons KGM, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, Reitsma JB, Collins GS (2014) Critical appraisal and data Extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLOS Med 11:e1001744. https://doi.org/10.1371/journal.pmed.1001744
Debray TP, Damen JA, Snell KI, Ensor J, Hooft L, Reitsma JB, Riley RD, Moons KG (2017) A guide to systematic review and meta-analysis of prediction model performance. BMJ 356:i6460. https://doi.org/10.1136/bmj.i6460
Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C (2013) Assessing bias in studies of prognostic factors. Ann Intern Med 158:280–286. https://doi.org/10.7326/0003-4819-158-4-201302190-00009
Bittar PG, Bittar JM, Etzkorn JR, Brewer JD, Aizman L, Shin TM, Sobanko JF, Higgins HW, Giordano CN, Cohen JV, Pride R, Wan MT, Leitenberger JJ, Bar AA, Aasi S, Bordeaux JS, Miller CJ (2021) Systematic review and meta-analysis of local recurrence rates of head and neck cutaneous melanomas after wide local excision, Mohs micrographic surgery, or staged excision. J Am Acad Dermatol 85:681–692. https://doi.org/10.1016/j.jaad.2021.04.090
Wennberg AM, Larkö O, Stenquist B (1999) Five-year results of Mohs’ micrographic surgery for aggressive facial basal cell carcinoma in Sweden. Acta Derm Venereol 79:370–372. https://doi.org/10.1080/000155599750010292
Boztepe G, Hohenleutner S, Landthaler M, Hohenleutner U (2004) Munich method of micrographic surgery for basal cell carcinomas: 5-year recurrence rates with life-table analysis. Acta Derm Venereol 84:218–222. https://doi.org/10.1080/00015550410025228
Leibovitch I, Huilgol SC, Selva D, Richards S, Paver R (2005) Basal cell carcinoma treated with Mohs surgery in Australia II. Outcome at 5-year follow-up. J Am Acad Dermatol 53:452–457. https://doi.org/10.1016/j.jaad.2005.04.087
Lawrence CM, Haniffa M, Dahl MG (2009) Formalin-fixed tissue Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data. Br J Dermatol 160:573–580. https://doi.org/10.1111/j.1365-2133.2008.09021.x
Paoli J, Daryoni S, Wennberg AM, Mölne L, Gillstedt M, Miocic M, Stenquist B (2011) 5-year recurrence rates of Mohs micrographic surgery for aggressive and recurrent facial basal cell carcinoma. Acta Derm Venereol 91:689–693. https://doi.org/10.2340/00015555-1134
Veronese F, Farinelli P, Zavattaro E, Zuccoli R, Bonvini D, Leigheb G, Colombo E (2012) Basal cell carcinoma of the head region: therapeutical results of 350 lesions treated with Mohs micrographic surgery. J Eur Acad Dermatol Venereol 26:838–843. https://doi.org/10.1111/j.1468-3083.2011.04165.x
Català A, Garces JR, Alegre M, Gich IJ, Puig L (2014) Mohs micrographic surgery for basal cell carcinomas: results of a Spanish retrospective study and Kaplan-Meier survival analysis of tumour recurrence. J Eur Acad Dermatol Venereol 28:1363–1369. https://doi.org/10.1111/jdv.12293
Mohs F, Larson P, Iriondo M (1988) Micrographic surgery for the microscopically controlled excision of carcinoma of the external ear. J Am Acad Dermatol 19:729–737. https://doi.org/10.1016/s0190-9622(88)70229-7
Mohs FE (1986) Micrographic surgery for the microscopically controlled excision of eyelid cancers. Arch Ophthalmol 104:901–909. https://doi.org/10.1001/archopht.1986.01050180135046
Mohs FE, Zitelli JA (1981) Microscopically controlled surgery in the treatment of carcinoma of the scalp. Arch Dermatol 117:764–769. https://doi.org/10.1001/archderm.1981.01650120010011
Robins P, Rodríguez-Sains R, Rabinovitz H, Rigel D (1985) Mohs surgery for periocular basal cell carcinomas. J Dermatol Surg Oncol 11:1203–1207. https://doi.org/10.1111/j.1524-4725.1985.tb03098.x
Viola KV, Jhaveri MB, Soulos PR, Turner RB, Tolpinrud WL, Doshi D, Gross CP (2012) Mohs micrographic surgery and surgical excision for nonmelanoma skin cancer treatment in the medicare population. Arch Dermatol 148:473–477. https://doi.org/10.1001/archdermatol.2011.2456
Aoyagi S (2011) International perspective of Mohs micrographic surgery: East Asia. Mohs Microgr Surg. https://doi.org/10.1007/978-1-4471-2152-7_42
Mora RG, Robins P (1978) Basal-cell carcinomas in the center of the face: special diagnostic, prognostic, and therapeutic considerations. J Dermatol Surg Oncol 4:315–321. https://doi.org/10.1111/j.1524-4725.1978.tb00435.x
Smith SP, Grande DJ (1991) Basal cell carcinoma recurring after radiotherapy: a unique, difficult treatment subclass of recurrent basal cell carcinoma. J Dermatol Surg Oncol 17:26–30. https://doi.org/10.1111/j.1524-4725.1991.tb01589.x
Freeman RG, Duncan C (1973) Recurrent skin cancer. Arch Dermatol 107:395–399. https://doi.org/10.1001/archderm.1973.01620180049015
Menn H, Robins P, Kopf AW, Bart RS (1971) The recurrent basal cell epithelioma. A study of 100 cases of recurrent, re-treated basal cell epitheliomas. Arch Dermatol 103:628–631. https://doi.org/10.1001/archderm.1971.04000180054007
Hirshowitz B, Mahler D (1971) Incurable recurrences of basal cell carcinoma of the mid-face following radiation therapy. Br J Plast Surg 24:205–211. https://doi.org/10.1016/s0007-1226(71)80042-5
Hruza GJ (1990) Mohs micrographie surgery. Otolaryngol Clin North Am 23:845–864. https://doi.org/10.1016/S0030-6665(20)31213-5
Batra RS, Kelley LC (2002) Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 138:1043–1051. https://doi.org/10.1001/archderm.138.8.1043
Bartoš V, Pokorný D, Zacharová O, Haluska P, Doboszová J, Kullová M, Adamicová K, Péč M, Péč J (2011) Recurrent basal cell carcinoma: a clinicopathological study and evaluation of histomorphological findings in primary and recurrent lesions. Acta Dermatovenerol Alp Pannonica Adriat 20:67–75
Flohil SC, van Dorst AM, Nijsten T, Martino Neumann HA, Munte K (2013) Mohs micrographic surgery for basal cell carcinomas: appropriateness of “Rotterdam” criteria and predictive factors for three or more stages. J Eur Acad Dermatol Venereol 27:1228–1235. https://doi.org/10.1111/j.1468-3083.2012.04696.x
Chen JT, Kempton SJ, Rao VK (2016) The economics of skin cancer: an analysis of Medicare payment data. Plast Reconstr Surg Glob Open 4:e868. https://doi.org/10.1097/GOX.0000000000000826
Nassiripour L, Amirsadri M, Tabatabaeian M, Maracy MR (2016) Cost-effectiveness of surgical excision versus Mohs micrographic surgery for nonmelanoma skin cancer: a retrospective cohort study. J Res Med Sci 21:91
Acknowledgements
We have received inspiration from Assoc. Prof. Dr. Nopadon Noppakun for this research topic. This meta-analysis could not have been accomplished without the kindness of Dr. Somkiat Potisat and Associate Professor Dr. Pojai Pattanittum, who provided critical suggestions for improvement of the manuscript. Moreover, we would like to thank Editage (www.editage.com) for careful English language editing.
Funding
This study has no funding.
Author information
Authors and Affiliations
Contributions
AS generated the research question and the outline of this meta-analysis. PP was involved in the research methodology and statistical analysis. MS and SS contributed to the study selection and abstract screening. SS wrote the introduction section of this paper. All authors commented on previous versions of the manuscript and have read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Apasee Sooksamran, Pitchayasak Pichai, Mingkwan Wichaidit, and Sasathorn Singthong declare that they have no conflict of interest.
Ethics approval
The study design was expedited by the appropriate ethics review board, Institutional Review Board of the Institute of Dermatology IRB/IEB038/2564, because this systematic review uses publicly accessible documents not involving in patient privacy.
Consent to participate/Consent to publish
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sooksamran, A., Pichai, P., Suphannaphong, M. et al. Previous therapy and the recurrence rate of basal cell carcinoma after Mohs surgery: a meta-analysis. Arch Dermatol Res 315, 1747–1754 (2023). https://doi.org/10.1007/s00403-023-02558-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02558-w